Who owns SEELOS THERAPEUTICS ORD?
- CUSIP Number: 81577f208
Tip: Access positions for across all investors
Analyze quarterly positions in Seelos Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seelos Therapeutics Ord stock
Who bought or sold SEELOS THERAPEUTICS ORD this quarter?
There are no current stakeholders of Seelos Therapeutics Ord.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Seelos Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AdvisorShares Investments | Mar 2024 | 463k | $274k |
| Balyasny Asset Management | Mar 2024 | 379k | $224k |
| Vanguard Group | Mar 2024 | 281k | $166k |
| Morgan Stanley | Mar 2024 | 126k | $75k |
| BlackRock | Mar 2024 | 56k | $33k |
| Two Sigma Investments | Mar 2024 | 13k | $7.7k |
| State Street Corporation | Mar 2024 | 13k | $7.7k |
| Tower Research Capital | Mar 2024 | 11k | $6.2k |
| Wealth Enhancement Advisory Services | Mar 2024 | 10k | $5.9k |
| Advisor Group Holdings | Mar 2024 | 8.2k | $4.8k |
| First Manhattan | Mar 2024 | 372.00 | $218.996400 |
| Hollencrest Securities | Mar 2024 | 86.00 | $50.998000 |
| Parallel Advisors | Jun 2024 | 3.00 | $2.000100 |